Categories
Change Password!
Reset Password!
Asia-Pacific experts introduce updated alopecia areata guidelines emphasizing trichoscopy and targeted therapies.
Alopecia areata (AA) is an immune-mediated hair loss disorder that affects individuals across all age groups, genders, and ethnic populations while substantially impairing emotional well-being and quality of life (QoL). An expert panel aimed to establish practical, region-focused recommendations for the diagnosis, severity assessment, and treatment of AA across diverse healthcare settings in the Asia-Pacific (APAC) region.
Eighteen dermatology experts representing Australia, China, India, Korea, Malaysia, Singapore, Taiwan, and Thailand participated in a modified Delphi consensus process conducted over three rounds. The process included :
These were used to evaluate key aspects of AA management. Consensus for Likert-scale and multiple-choice statements was defined as at least 70% agreement or disagreement among panel members. The panel achieved consensus on 140 clinical statements addressing epidemiology, diagnosis, severity classification, and treatment strategies for AA.
The expert-driven consensus established a structured and clinically relevant framework for the diagnosis and management of AA within the APAC region. The recommendations strengthened the role of standardized assessment tools and evidence-based therapeutic strategies while addressing regional variations in healthcare practice. The guidance also underscored the growing importance of targeted therapies and early disease evaluation in improving long-term patient outcomes and QoL.
International Journal of Dermatology
Epidemiology, Diagnosis and Management of Alopecia Areata: An Asia-Pacific Modified Delphi Expert Panel Recommendations
Rodney Sinclair et al.
Comments (0)